News | July 02, 2022
Ardelyx gets into $20 million financing agreement with HealthCare Royalty Partners
HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States
HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States
The plan is to advance innovative therapies to drug-resistant cancers
Appoints Dr Rafiq Hasan as CEO
The bank will provide a complete range of financing options including hospitals, labs, diagnostic centres and equipment manufacturers
In addition to supporting the ongoing development of the first IND-approved product in clinical trials, the proceeds will also be used to expand the 3D printed drug product pipeline
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
Landmark procedure restores 32-year-old CKD patient’s health, highlighting how public insurance is widening access to advanced renal care
Minister highlights RDI fund, private participation in space and nuclear sectors, and calls for faster reforms to improve ease of research in India
The new capital is expected to fund the company through 2029
Subscribe To Our Newsletter & Stay Updated
